Daxor Corporation (DXR)
USD 8.0
(2.56%)
USD 8.0
(2.56%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 280.64 Thousand USD | -94.58% |
| 2022 | 5.17 Million USD | 9.05% |
| 2021 | 4.74 Million USD | 378.42% |
| 2020 | -1.7 Million USD | -244.04% |
| 2019 | -495.69 Thousand USD | 44.04% |
| 2018 | -885.77 Thousand USD | 28.56% |
| 2017 | -1.23 Million USD | -185.17% |
| 2016 | 1.45 Million USD | 115.92% |
| 2015 | -9.14 Million USD | -836.45% |
| 2014 | -976.7 Thousand USD | 88.12% |
| 2013 | -8.21 Million USD | -792.38% |
| 2012 | 1.18 Million USD | 116.52% |
| 2011 | -7.18 Million USD | -244.63% |
| 2010 | 4.96 Million USD | -14.68% |
| 2009 | 5.82 Million USD | -61.5% |
| 2008 | 15.12 Million USD | 42.04% |
| 2007 | 10.64 Million USD | 1455.42% |
| 2006 | -785.53 Thousand USD | 41.2% |
| 2005 | -1.33 Million USD | -130.24% |
| 2004 | -580.26 Thousand USD | 46.08% |
| 2003 | -1.07 Million USD | -455.16% |
| 2002 | -193.85 Thousand USD | -164.76% |
| 2001 | 299.35 Thousand USD | 642.37% |
| 2000 | -55.19 Thousand USD | 43.19% |
| 1999 | -97.15 Thousand USD | 75.71% |
| 1998 | -400 Thousand USD | -100.0% |
| 1997 | -200 Thousand USD | -100.0% |
| 1996 | -100 Thousand USD | -107.69% |
| 1995 | 1.3 Million USD | -27.78% |
| 1994 | 1.8 Million USD | -18.18% |
| 1993 | 2.2 Million USD | -35.29% |
| 1992 | 3.4 Million USD | 278.95% |
| 1991 | -1.9 Million USD | -165.52% |
| 1990 | 2.9 Million USD | 680.0% |
| 1989 | -500 Thousand USD | -114.71% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -815.4 Thousand USD | 0.0% |
| 2024 Q1 | -815.4 Thousand USD | -124.58% |
| 2023 Q3 | 1.65 Million USD | 154.62% |
| 2023 Q1 | -1.51 Million USD | -121.72% |
| 2023 FY | 280.64 Thousand USD | -94.58% |
| 2023 Q4 | 3.31 Million USD | 100.0% |
| 2023 Q2 | -3.03 Million USD | -100.0% |
| 2022 Q4 | 6.99 Million USD | 100.0% |
| 2022 Q3 | 3.49 Million USD | -13.48% |
| 2022 Q1 | -906.24 Thousand USD | -122.45% |
| 2022 FY | 5.17 Million USD | 9.05% |
| 2022 Q2 | 4.04 Million USD | 545.81% |
| 2021 Q3 | 3.14 Million USD | -21.95% |
| 2021 Q2 | 4.03 Million USD | 620.95% |
| 2021 FY | 4.74 Million USD | 378.42% |
| 2021 Q4 | 4.03 Million USD | 28.19% |
| 2021 Q1 | -774.33 Thousand USD | -119.2% |
| 2020 Q1 | -1.77 Million USD | -147.35% |
| 2020 Q2 | 3.83 Million USD | 316.35% |
| 2020 FY | -1.7 Million USD | -244.04% |
| 2020 Q3 | 921.45 Thousand USD | -75.99% |
| 2020 Q4 | 4.03 Million USD | 337.77% |
| 2019 Q3 | -465.8 Thousand USD | -206.86% |
| 2019 FY | -495.69 Thousand USD | 44.04% |
| 2019 Q1 | 217.95 Thousand USD | 282.73% |
| 2019 Q2 | 435.91 Thousand USD | 100.0% |
| 2019 Q4 | 3.74 Million USD | 904.38% |
| 2018 Q1 | -323.6 Thousand USD | -1.71% |
| 2018 Q3 | -119.27 Thousand USD | 63.14% |
| 2018 Q4 | -119.27 Thousand USD | 0.0% |
| 2018 FY | -885.77 Thousand USD | 28.56% |
| 2018 Q2 | -323.6 Thousand USD | 0.0% |
| 2017 Q3 | -318.16 Thousand USD | -5.43% |
| 2017 Q4 | -318.16 Thousand USD | 0.0% |
| 2017 FY | -1.23 Million USD | -185.17% |
| 2017 Q1 | -301.78 Thousand USD | -221.13% |
| 2017 Q2 | -301.78 Thousand USD | 0.0% |
| 2016 Q2 | 821.85 Thousand USD | 0.0% |
| 2016 FY | 1.45 Million USD | 115.92% |
| 2016 Q4 | -93.97 Thousand USD | 0.0% |
| 2016 Q3 | -93.97 Thousand USD | -111.43% |
| 2016 Q1 | 821.85 Thousand USD | 135.23% |
| 2015 FY | -9.14 Million USD | -836.45% |
| 2015 Q3 | -2.33 Million USD | -4.11% |
| 2015 Q4 | -2.33 Million USD | 0.0% |
| 2015 Q2 | -2.24 Million USD | 0.0% |
| 2015 Q1 | -2.24 Million USD | -792.13% |
| 2014 Q2 | -237.2 Thousand USD | 0.0% |
| 2014 FY | -976.7 Thousand USD | 88.12% |
| 2014 Q1 | -237.2 Thousand USD | 88.06% |
| 2014 Q4 | -251.14 Thousand USD | 0.0% |
| 2014 Q3 | -251.14 Thousand USD | -5.87% |
| 2013 Q4 | -1.98 Million USD | 0.0% |
| 2013 Q1 | -2.12 Million USD | -241.73% |
| 2013 FY | -8.21 Million USD | -792.38% |
| 2013 Q3 | -1.98 Million USD | 6.39% |
| 2013 Q2 | -2.12 Million USD | 0.0% |
| 2012 FY | 1.18 Million USD | 116.52% |
| 2012 Q4 | 1.49 Million USD | 0.0% |
| 2012 Q3 | 1.49 Million USD | 0.0% |
| 2011 Q1 | -1.32 Million USD | -158.49% |
| 2011 Q3 | -4.18 Million USD | -2167.33% |
| 2011 Q4 | -1.49 Million USD | 64.36% |
| 2011 FY | -7.18 Million USD | -244.63% |
| 2011 Q2 | -184.52 Thousand USD | 86.09% |
| 2010 FY | 4.96 Million USD | -14.68% |
| 2010 Q4 | 2.26 Million USD | -12.95% |
| 2010 Q3 | 2.6 Million USD | 1282.92% |
| 2010 Q2 | 188.35 Thousand USD | 303.81% |
| 2010 Q1 | -92.41 Thousand USD | 93.83% |
| 2009 Q4 | -1.49 Million USD | -157.07% |
| 2009 FY | 5.82 Million USD | -61.5% |
| 2009 Q1 | -1.54 Million USD | -1385.03% |
| 2009 Q2 | 6.23 Million USD | 504.25% |
| 2009 Q3 | 2.62 Million USD | -57.91% |
| 2008 Q1 | 7.32 Million USD | 122.41% |
| 2008 Q3 | 6.4 Million USD | 325.38% |
| 2008 Q4 | -103.92 Thousand USD | -101.62% |
| 2008 FY | 15.12 Million USD | 42.04% |
| 2008 Q2 | 1.5 Million USD | -79.44% |
| 2007 Q2 | 2.33 Million USD | -23.53% |
| 2007 FY | 10.64 Million USD | 1455.42% |
| 2007 Q3 | 1.95 Million USD | -16.42% |
| 2007 Q1 | 3.05 Million USD | 6421.31% |
| 2007 Q4 | 3.29 Million USD | 68.32% |
| 2006 Q1 | -38.98 Thousand USD | 95.62% |
| 2006 Q4 | 46.92 Thousand USD | 105.06% |
| 2006 Q3 | -927.79 Thousand USD | -790.73% |
| 2006 Q2 | 134.32 Thousand USD | 444.57% |
| 2006 FY | -785.53 Thousand USD | 41.2% |
| 2005 Q1 | -340.03 Thousand USD | -21.61% |
| 2005 Q2 | -1.09 Million USD | -221.16% |
| 2005 Q3 | 995.82 Thousand USD | 191.19% |
| 2005 Q4 | -889.02 Thousand USD | -189.28% |
| 2005 FY | -1.33 Million USD | -130.24% |
| 2004 Q2 | -261.46 Thousand USD | -1422.92% |
| 2004 Q3 | -58.96 Thousand USD | 77.45% |
| 2004 Q4 | -279.6 Thousand USD | -374.16% |
| 2004 FY | -580.26 Thousand USD | 46.08% |
| 2004 Q1 | 19.76 Thousand USD | 105.29% |
| 2003 Q4 | -373.9 Thousand USD | -107.68% |
| 2003 FY | -1.07 Million USD | -455.16% |
| 2003 Q3 | -180.04 Thousand USD | 27.3% |
| 2003 Q1 | -274.58 Thousand USD | 32.95% |
| 2003 Q2 | -247.65 Thousand USD | 9.81% |
| 2002 Q1 | 32.57 Thousand USD | 24.49% |
| 2002 Q4 | -409.52 Thousand USD | -489.99% |
| 2002 Q2 | 78.09 Thousand USD | 139.73% |
| 2002 FY | -193.85 Thousand USD | -164.76% |
| 2002 Q3 | 105 Thousand USD | 34.47% |
| 2001 Q2 | 93.71 Thousand USD | 131.33% |
| 2001 Q1 | 40.51 Thousand USD | 126.34% |
| 2001 FY | 299.35 Thousand USD | 642.37% |
| 2001 Q4 | 26.16 Thousand USD | -81.17% |
| 2001 Q3 | 138.96 Thousand USD | 48.29% |
| 2000 FY | -55.19 Thousand USD | 43.19% |
| 2000 Q2 | -61.76 Thousand USD | -165.71% |
| 2000 Q1 | 93.99 Thousand USD | 131.63% |
| 2000 Q3 | 66.35 Thousand USD | 207.44% |
| 2000 Q4 | -153.77 Thousand USD | -331.76% |
| 1999 Q1 | 300 Thousand USD | 250.0% |
| 1999 FY | -97.15 Thousand USD | 75.71% |
| 1999 Q4 | -297.15 Thousand USD | 0.0% |
| 1999 Q3 | - USD | 100.0% |
| 1999 Q2 | -100 Thousand USD | -133.33% |
| 1998 Q4 | -200 Thousand USD | 0.0% |
| 1998 Q2 | 100 Thousand USD | 150.0% |
| 1998 FY | -400 Thousand USD | -100.0% |
| 1998 Q3 | - USD | -100.0% |
| 1998 Q1 | -200 Thousand USD | 80.0% |
| 1997 Q2 | - USD | -100.0% |
| 1997 Q1 | 300 Thousand USD | 0.0% |
| 1997 FY | -200 Thousand USD | -100.0% |
| 1997 Q4 | -1 Million USD | -350.0% |
| 1997 Q3 | 400 Thousand USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q2 | - USD | 100.0% |
| 1996 Q1 | -100 Thousand USD | -150.0% |
| 1996 FY | -100 Thousand USD | -107.69% |
| 1996 Q4 | - USD | 0.0% |
| 1995 FY | 1.3 Million USD | -27.78% |
| 1995 Q3 | 200 Thousand USD | -33.33% |
| 1995 Q2 | 300 Thousand USD | -50.0% |
| 1995 Q1 | 600 Thousand USD | 100.0% |
| 1995 Q4 | 200 Thousand USD | 0.0% |
| 1994 FY | 1.8 Million USD | -18.18% |
| 1994 Q4 | 300 Thousand USD | -25.0% |
| 1994 Q3 | 400 Thousand USD | -20.0% |
| 1994 Q2 | 500 Thousand USD | 0.0% |
| 1994 Q1 | 500 Thousand USD | -44.44% |
| 1993 Q2 | 700 Thousand USD | 275.0% |
| 1993 Q4 | 900 Thousand USD | -10.0% |
| 1993 Q1 | -400 Thousand USD | 20.0% |
| 1993 Q3 | 1 Million USD | 42.86% |
| 1993 FY | 2.2 Million USD | -35.29% |
| 1992 FY | 3.4 Million USD | 278.95% |
| 1992 Q4 | -500 Thousand USD | -145.45% |
| 1992 Q3 | 1.1 Million USD | -38.89% |
| 1992 Q2 | 1.8 Million USD | 80.0% |
| 1992 Q1 | 1 Million USD | 233.33% |
| 1991 Q3 | 600 Thousand USD | 200.0% |
| 1991 Q4 | 300 Thousand USD | -50.0% |
| 1991 Q1 | -3 Million USD | -433.33% |
| 1991 Q2 | 200 Thousand USD | 106.67% |
| 1991 FY | -1.9 Million USD | -165.52% |
| 1990 FY | 2.9 Million USD | 680.0% |
| 1990 Q3 | 500 Thousand USD | -16.67% |
| 1990 Q2 | 600 Thousand USD | -33.33% |
| 1990 Q1 | 900 Thousand USD | 0.0% |
| 1990 Q4 | 900 Thousand USD | 80.0% |
| 1989 FY | -500 Thousand USD | -114.71% |
| 1989 Q2 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 100.443% |
| AngioDynamics, Inc. | -184.34 Million USD | 100.152% |
| AtriCure, Inc. | -30.43 Million USD | 100.922% |
| Avinger, Inc. | -18.32 Million USD | 101.532% |
| Azenta, Inc. | -14.25 Million USD | 101.968% |
| BioLife Solutions, Inc. | -66.42 Million USD | 100.422% |
| The Cooper Companies, Inc. | 294.2 Million USD | 99.905% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 101.847% |
| Femasys Inc. | -14.24 Million USD | 101.97% |
| GlucoTrack, Inc. | -7.09 Million USD | 103.954% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 108.218% |
| Hologic, Inc. | 789.5 Million USD | 99.964% |
| ICU Medical, Inc. | -29.65 Million USD | 100.946% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 99.984% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 102.042% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 99.068% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 104.212% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 104.212% |
| Masimo Corporation | 81.5 Million USD | 99.656% |
| Microbot Medical Inc. | -10.74 Million USD | 102.613% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 97.586% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 99.703% |
| Nephros, Inc. | -1.57 Million USD | 117.818% |
| NovoCure Limited | -207.04 Million USD | 100.136% |
| NEXGEL, Inc. | -3.15 Million USD | 108.889% |
| NEXGEL, Inc. | -3.15 Million USD | 108.889% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 100.296% |
| OraSure Technologies, Inc. | 53.65 Million USD | 99.477% |
| Pro-Dex, Inc. | 2.12 Million USD | 86.806% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 100.665% |
| Predictive Oncology Inc. | -13.98 Million USD | 102.007% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 109.509% |
| QuidelOrtho Corporation | -10.1 Million USD | 102.779% |
| Repligen Corporation | 41.57 Million USD | 99.325% |
| Sanara MedTech Inc. | -4.3 Million USD | 106.522% |
| STAAR Surgical Company | 21.34 Million USD | 98.685% |
| Sharps Technology, Inc. | -9.84 Million USD | 102.852% |
| Utah Medical Products, Inc. | 16.63 Million USD | 98.313% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 100.213% |
| Jin Medical International Ltd. | 2.87 Million USD | 90.25% |